Intrahepatic cholangiocarcinoma presenting intrabile duct tumor growth: report of a case.
Tsuyoshi Sano(Aichi Medical University), Setsuo Hirohashi(National Cancer Research Institute), Junji Yamamoto(The Cancer Institute Hospital), Michiie Sakamoto(Keio University), Kazuto Inoue(Nihon University), Tadatoshi Takayama(Nihon University), Tomoo Kosuge(Tokyo National Hospital), Kazuaki Shimada(Japan Aerospace Exploration Agency), Susumu Yamazaki
PubMed
January 14, 1997
Cited by 6
Related Papers
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
|Journal of Hepatology|2003|1.6k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Ultrasonically guided subsegmentectomy.
|PubMed|1985|823
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma
|Annals of Surgery|2005|641